6-Mar-2026
TipRanks (Tue, 3-Mar 10:11 AM ET)
Top InfuSystem Executive Makes Bold Insider Move on Company Stock
TipRanks (Mon, 2-Mar 9:06 PM ET)
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
Business Wire (Tue, 24-Feb 6:30 AM ET)
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Business Wire (Tue, 17-Feb 6:30 AM ET)
Business Wire (Wed, 10-Dec 5:37 PM ET)
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Infusystems Holdings trades on the AMEX stock market under the symbol INFU.
As of March 6, 2026, INFU stock price declined to $9.48 with 95,221 million shares trading.
INFU has a beta of 1.77, meaning it tends to be more sensitive to market movements. INFU has a correlation of 0.21 to the broad based SPY ETF.
INFU has a market cap of $192.79 million. This is considered a Micro Cap stock.
Last quarter Infusystems Holdings reported $36 million in Revenue and $.10 earnings per share. This fell short of revenue expectation by $-376,200 and exceeded earnings estimates by $.03.
In the last 3 years, INFU traded as high as $11.44 and as low as $4.61.
The top ETF exchange traded funds that INFU belongs to (by Net Assets): VTI, AVUV, VXF, DFAS, DFAT.
INFU has outperformed the market in the last year with a price return of +51.7% while the SPY ETF gained +18.7%. INFU has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +6.6% and +19.2%, respectively, while the SPY returned -1.7% and -2.5%, respectively.
INFU support price is $9.31 and resistance is $10.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INFU shares will trade within this expected range on the day.